Correlation Between Mineralys Therapeutics, and Quoin Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Quoin Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Quoin Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Quoin Pharmaceuticals Ltd, you can compare the effects of market volatilities on Mineralys Therapeutics, and Quoin Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Quoin Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Quoin Pharmaceuticals.
Diversification Opportunities for Mineralys Therapeutics, and Quoin Pharmaceuticals
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Mineralys and Quoin is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Quoin Pharmaceuticals Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quoin Pharmaceuticals and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Quoin Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quoin Pharmaceuticals has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Quoin Pharmaceuticals go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Quoin Pharmaceuticals
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 0.55 times more return on investment than Quoin Pharmaceuticals. However, Mineralys Therapeutics, Common is 1.8 times less risky than Quoin Pharmaceuticals. It trades about -0.01 of its potential returns per unit of risk. Quoin Pharmaceuticals Ltd is currently generating about -0.08 per unit of risk. If you would invest 1,854 in Mineralys Therapeutics, Common on November 2, 2024 and sell it today you would lose (833.00) from holding Mineralys Therapeutics, Common or give up 44.93% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Quoin Pharmaceuticals Ltd
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Quoin Pharmaceuticals |
Mineralys Therapeutics, and Quoin Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Quoin Pharmaceuticals
The main advantage of trading using opposite Mineralys Therapeutics, and Quoin Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Quoin Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quoin Pharmaceuticals will offset losses from the drop in Quoin Pharmaceuticals' long position.| Mineralys Therapeutics, vs. SEI Investments | Mineralys Therapeutics, vs. Carlyle Group | Mineralys Therapeutics, vs. Centessa Pharmaceuticals PLC | Mineralys Therapeutics, vs. Alto Neuroscience, |
| Quoin Pharmaceuticals vs. Revelation Biosciences | Quoin Pharmaceuticals vs. Virax Biolabs Group | Quoin Pharmaceuticals vs. Allarity Therapeutics | Quoin Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |